Top

Published in:

01-06-2013

Development of a Question Prompt List as a Communication Intervention to Reduce Racial Disparities in Cancer Treatment

Authors: Susan Eggly, Rifky Tkatch, Louis A. Penner, Lorna Mabunda, Janella Hudson, Robert Chapman, Jennifer J. Griggs, Richard Brown, Terrance Albrecht

Published in: Journal of Cancer Education | Issue 2/2013

Abstract

Racial disparities have been found in the use of chemotherapy as cancer treatment. These disparities may be, in part, due to well-documented differences in the quality of communication during clinical interactions with oncologists and Black versus White patients. In this study using a community-based participatory research approach, academic researchers, community members, and oncologists formed a partnership to develop a communication intervention to address racial disparities in cancer care. Partners developed a question prompt list (QPL), a simple tool that can be used to improve communication, and thus treatment, during clinical interactions in which oncologists and Black patients discuss chemotherapy. Partners endorsed the use of a QPL, provided specific suggestions for content and format, conducted and analyzed qualitative interviews with Black patients receiving chemotherapy, and approved the final version. The feasibility and effectiveness of the QPL that resulted from this research process are currently under evaluation in a separate study

Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW (2003) Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81(1):21–31PubMedCrossRef

Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357PubMedCrossRef

Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD (2008) Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst 100(10):738–744PubMedCrossRef

Berger M, Lund MJ, Brawley OW (2007) Racial disparities in lung cancer. Curr Probl Cancer 31(3):202–210PubMedCrossRef

Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH (2007) Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol 25(18):2522–2527PubMedCrossRef

Lin CC, Virgo KS (2013) Association between the availability of medical oncologists and initiation of chemotherapy for patients with stage III colon cancer. J Oncol Pract 9(1):27–33PubMedCrossRef

Jean-Pierre P, Fiscella K, Griggs J, Joseph JV, Morrow G, Carroll J, Hendren S et al (2010) Race/ethnicity-based concerns over understanding cancer diagnosis and treatment plan. J Natl Med Assoc 102(3):184–189PubMed

Eggly S, Harper FW, Penner LA, Gleason MJ, Foster T, Albrecht TL (2011) Variation in question asking during cancer clinical interactions: a potential source of disparities in access to information. Patient Educ Couns 82(1):63–68PubMedCrossRef

Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR (2003) Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med 139(11):907–915PubMedCrossRef

10.

Johnson RL, Roter D, Powe NR, Cooper LA (2004) Patient race/ethnicity and quality of patient–physician communication during medical visits. Am J Public Health 94(12):2084–2090PubMedCrossRef

11.

Gordon HS, Street RL Jr, Sharf BF, Souchek J (2006) Racial differences in doctors’ information-giving and patients’ participation. Cancer 107(6):1313–1320PubMedCrossRef

12.

Siminoff LA, Graham GC, Gordon NH (2006) Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors. Patient Educ Couns 62(3):355–360PubMedCrossRef

13.

Song L, Hamilton JB, Moore AD (2012) Patient–healthcare provider communication: perspectives of African American cancer patients. Health Psychol 31(5):539–547PubMedCrossRef

14.

Eggly S, Barton E, Winckles A, Penner LA, Albrecht TL (2012) A disparity of words: A comparison of offers to participate in cancer clinical trials by patient race. Submitted to the Fifth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, San Diego, California

15.

Gordon HS, Street RL Jr, Sharf BF, Kelly PA, Souchek J (2006) Racial differences in trust and lung cancer patients’ perceptions of physician communication. J Clin Oncol 24(6):904–909PubMedCrossRef

16.

Epstein RM, Street RL Jr (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, Bethesda, NIH Publication No 07-6225

17.

Stewart M, Brown JB, Donner A, McWhinney IR, Oates J, Weston WW, Jordan J (2000) The impact of patient-centered care on outcomes. J Fam Pract 49(9):796–804PubMed

18.

Albrecht TL, Eggly SS, Gleason ME, Harper FW, Foster TS, Peterson AM, Orom H, Penner LA, Ruckdeschel JC (2008) Influence of clinical communication on patients’ decision making on participation in clinical trials. J Clin Oncol 26(16):2666–2673PubMedCrossRef

19.

Kaplan SH, Greenfield S, Ware JE Jr (1989) Assessing the effects of physician–patient interactions on the outcomes of chronic disease. Med Care 27(3 Suppl):S110–127PubMedCrossRef

20.

Beach MC, Keruly J, Moore RD (2006) Is the quality of the patient–provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med 21(6):661–665PubMedCrossRef

21.

Dimoska A, Butow PN, Lynch J, Hovey E, Agar M, Beale P, Tattersall MH (2012) Implementing patient question-prompt lists into routine cancer care. Patient Educ Couns 86(2):252–258PubMedCrossRef

22.

Dimoska A, Tattersall MH, Butow PN, Shepherd H, Kinnersley P (2008) Can a “prompt list” empower cancer patients to ask relevant questions? Cancer 113(2):225–237PubMedCrossRef

23.

Brown RF, Butow PN, Dunn SM, Tattersall MH (2001) Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer 85(9):1273–1279PubMedCrossRef

24.

Cegala DJ, Street RL Jr, Clinch CR (2007) The impact of patient participation on physicians’ information provision during a primary care medical interview. Health Commun 21(2):177–185PubMedCrossRef

25.

Cegala DJ, Chisolm DJ, Nwomeh BC (2012) Further examination of the impact of patient participation on physicians’ communication style. Patient Educ Couns 89(1):25–30PubMedCrossRef

26.

Langbecker D, Janda M, Yates P (2012) Development and piloting of a brain tumour-specific question prompt list. Eur J Cancer Care 21(4):517–526CrossRef

27.

Brown RF, Bylund CL, Li Y, Edgerson S, Butow P (2012) Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations. Patient Educ Couns 88(2):311–317PubMedCrossRef

28.

Clayton J, Butow P, Tattersall M, Chye R, Noel M, Davis JM, Glare P (2003) Asking questions can help: development and preliminary evaluation of a question prompt list for palliative care patients. Br J Cancer 89(11):2069–2077PubMedCrossRef

29.

Clayton JM, Butow PN, Tattersall MH, Devine RJ, Simpson JM, Aggarwal G, Clark KJ et al (2007) Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care. J Clin Oncol 25(6):715–723PubMedCrossRef

30.

Butow P, Devine R, Boyer M, Pendlebury S, Jackson M, Tattersall MH (2004) Cancer consultation preparation package: changing patients but not physicians is not enough. J Clin Oncol 22(21):4401–4409PubMedCrossRef

31.

Henselmans I., de Haes H. C, Smets E.M. (2012) Enhancing patient participation in oncology consultations: a best evidence synthesis of patient-targeted interventions. Psychooncology. DOI: 10.1002/pon.3099

32.

Penner LA, Eggly S, Griggs JJ, Orom H, Underwood W, Albrecht TL (2012) Life-threatening disparities: the treatment of Black and White cancer patients. J Soc Issues 68:328–257CrossRef

33.

De las Nueces D, Hacker K, DiGirolamo A, Hicks LS (2012) A systematic review of community-based participatory research to enhance clinical trials in racial and ethnic minority groups. Heal Serv Res 47(3 Pt 2):1363–1386CrossRef

34.

Israel BA, Krieger J, Vlahov D, Ciske S, Foley M, Fortin P, Guzman JR et al (2006) Challenges and facilitating factors in sustaining community-based participatory research partnerships: lessons learned from the Detroit, New York City and Seattle Urban Research Centers. J Urban Health 83(6):1022–1040PubMedCrossRef

35.

Israel BA, Eng E, Schulz AJ, Parker EA (2005) Introduction to methods in community-based participatory research for health. In: Israel BA, Eng E, Schultz AJ, Parker EA (eds) Methods in community-based participatory research for health. Jossey-Bass, San Francisco, pp 3–26

36.

Gehlert S, Coleman R (2010) Using community-based participatory research to ameliorate cancer disparities. Heal Soc Work 35(4):302–309CrossRef

37.

Meade CD, Menard JM, Luque JS, Martinez-Tyson D, Gwede CK (2011) Creating community–academic partnerships for cancer disparities research and health promotion. Heal Promot Pract 12(3):456–462CrossRef

38.

Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, Grimshaw JM (2010) What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Heal 25(10):1229–1245CrossRef

39.

Corbin J, Strauss A (2008) Basics of qualitative research: techniques and procedures for developing grounded theory, 3rd Aufl. Sage, London

40.

Charmaz K (2006) Constructing grounded theory. Sage, London

41.

Ryan GW, Bernard HR (2000) Data management and analysis methods. In: Denzin NK, Lincoln YS (eds) Handbook of qualitative research. Sage, Thousand Oaks, pp 769–802

Title: Development of a Question Prompt List as a Communication Intervention to Reduce Racial Disparities in Cancer Treatment
Authors: Susan Eggly
Rifky Tkatch
Louis A. Penner
Lorna Mabunda
Janella Hudson
Robert Chapman
Jennifer J. Griggs
Richard Brown
Terrance Albrecht
Publication date: 01-06-2013
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 2/2013
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-013-0456-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Pap Screening Goals and Perceptions of Pain among Black, Latina, and Arab Women: Steps Toward Breaking down Psychological Barriers

A Comparison of Attitudes Toward Euthanasia Among Medical Students at Two Polish Universities

The Value of an Educational Video Before Consultation with a Radiation Oncologist

Passing the Torch

Debunking ‘Race’ and Asserting Social Determinants as Primary Causes of Cancer Health Disparities: Outcomes of a Science Education Activity for Teens

Patient Distress and Emotional Disclosure: A Study of Chinese Cancer Patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer